Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel

BACKGROUND: Low density lipoprotein (LDL) has been regarded as a promising antitumor drug vehicle. However some problems, such as rare source, difficulty of large-scale production, and potential safety concerns, hinder its clinical application. PURPOSE: The objective of this study is to develop a bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Junyi, Xu, Ningze, Zhou, Xu, Shi, Kaihong, Du, Qian, Yin, Xiaoxing, Zhao, Ziming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751769/
https://www.ncbi.nlm.nih.gov/pubmed/31686815
http://dx.doi.org/10.2147/IJN.S215080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751769/
https://www.ncbi.nlm.nih.gov/pubmed/31686815
http://dx.doi.org/10.2147/IJN.S215080

Ejemplares similares